Skip to main content

Unichem Laboratories Ltd

NSE: UNICHEMLAB BSE: 506690

Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas.[1]

377
52W: ₹278 — ₹668
PE 124 · Book ₹344 · +10% vs book
Market Cap₹2,654 Cr
Stock P/E124Price to Earnings
ROCE7.49%Return on Capital
ROE6.67%Return on Equity
Div. Yield0%Face Value ₹2

Strengths

  • +Company is almost debt free.
  • +Stock is trading at 1.05 times its book value
  • +Company has delivered good profit growth of 37.4% CAGR over last 5 years

Weaknesses

  • Company has a low return on equity of -1.02% over last 3 years.
  • Earnings include an other income of Rs.293 Cr.
  • Company has high debtors of 157 days.

Shareholding Pattern

Promoters70.22%
FIIs1%
DIIs10.63%
Public18.14%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters70.22%70.22%70.22%70.22%70.22%70.22%70.22%70.22%
FIIs0.89%0.94%0.01.05%0.10.98%0.10.98%0.99%0.00.99%1%0.0
DIIs11.57%11.65%0.111.63%0.011.32%0.310.92%0.410.74%0.210.73%0.010.63%0.1
Public17.32%17.17%0.117.11%0.117.47%0.417.88%0.418.04%0.218.05%0.018.14%0.1

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales334362399390437448461384357315
Expenses341343369350372374386359349314
Operating Profit-71931406474752681
OPM %-2%5%8%10%15%17%16%7%2%0%
Net Profit-3169-11521434751-2-40216
EPS ₹-4.389.84-16.333.056.166.667.27-0.26-5.6730.69

AI Insights

Revenue Trend

TTM revenue at ₹1,517Cr, down 12.6% YoY. OPM at 7%.

Debt Position

Borrowings at ₹90Cr. Debt-to-equity ratio: 0.04x. Healthy balance sheet.

Capex Cycle

CWIP at ₹79Cr (6% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 10.63% (+0.98pp change). FIIs: 1% (-0.62pp change). Promoters hold 70.22%.

Margin & Efficiency

ROCE declining from 19% (Mar 2014) to 7% (Mar 2025). Working capital days: 202.

Valuation

PE 124x with 7.49% ROCE. Price is 10% above book value of ₹344. Dividend yield: 0%.

Recent Announcements